Brian Miller

Brian Miller, M.D., M.B.A., M.P.H. is an Assistant Professor of Medicine and Business (courtesy) at the Johns Hopkins University, where he is a practicing hospitalist, health policy researcher, and health policy analyst. He is a consultant to the FTC Bureau of Consumer Protection on health insurance and is a member of the Medicare Evidence Development & Coverage Advisory Committee, the UNC-NC State Biomedical Engineering Department Industrial Advisory Board, and the Keck Graduate Institute School of Medicine Dean's Advisory Council.

Dr. Miller also serves as an adjunct faculty at the UNC Kenan-Flagler School of Business, where he teaches insurance design in the MBA program. He previously served as a Medical Officer in the Office of New Drugs at the Center for Drug Evaluation and Research at the FDA, where he was one of two physician reviewers who completed the pre-market review of valbenazine, a first-in-class, breakthrough new molecular entity indicated for tardive dyskinesia. He completed both an Internal Medicine residency at Georgetown University Hospital and a Public Health Residency at Johns Hopkins University, comprised of a federal regulatory rotational program with postings at CMS, FTC, FCC, and FDA, while practicing ambulatory medicine at Johns Hopkins Community Physicians.

Dr. Miller has experience with healthcare merger review, healthcare finance innovation, and pharmaceutical product review. He previously served as a Special Advisor to the FTC's Office of Policy Planning and concurrently as an in-house physician expert for the Bureau of Competition, assisting in merger review & enforcement in health systems, PBMs, and pharmaceuticals, including the FTC's successful action blocking the $7 billion Advocate - NorthShore merger. Prior to the FTC, Dr. Miller was a Fellow at the CMS Innovation Center, where he co-managed the ACO Investment Model, a $114 million project focused on ACOs in rural areas. He is board-certified & licensed to practice medicine in DC and Maryland.

EXPERTISE

• Hospitalist, Internal Medicine, Preventive Medicine

RESEARCH INTERESTS

• Payment Policy; FDA Regulatory Policy; Healthcare Competition Policy

Selected Publications

Miller BJ, Wolfe G Managed Care Marketplaces: Growing Drivers of Payer-Provider Vertical Integration, Antitrust Source April 2017;16(5):1-11

Davis MC, Miller BJ, Kalsi J, Birkner T, Mathis MV. Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia. The New England Journal of Medicine 2017;376:2503-2506

Miller BJ, Slota J, Ehrenfeld JM Redefining the Physician’s Role in Cost Conscious Care JAMA 2019;322(8):721-722

Meshnick A, Miller BJ, Lushniak BD How FDA Can Act On E-Cigarettes And Protect The Public Health. Health Affairs Blog September 17, 2019

Miller BJ, Zima S. Exceptions for Exceptional Cures: Modernizing the Medicaid Drug Rebate Program. JAMA Health Forum August 31, 2020